Ads
related to: bristol-myers squibb
Search results
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
The Wall Street Journal· 2 days agoBristol Myers Squibb said its trial evaluating a combination of cancer treatments failed to meet its...
Fisher Asset Management LLC Acquires 127,228 Shares of Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 6 days agoFisher Asset Management LLC increased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 130.7% in the 4th quarter, according to the company in its most recent filing with the ...
Is Bristol Myers' Dividend in Danger?
Motley Fool via Yahoo Finance· 1 day agoBristol Myers Squibb (NYSE: BMY) pays investors an attractive dividend, which yields an incredibly high rate of 5.5%. That's nearly four times the S&P...
Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip
The Motley Fool via AOL· 11 hours agoAbout once every 90 days, publicly traded companies have to face their shareholders and let them...
Bristol Myers Squibb reports setback in lung cancer trial By Investing.com
Investing.com· 2 days agoBristol Myers Squibb (NYSE: NYSE:BMY) disclosed that its Phase 3 CheckMate -73L trial for treating a...
Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution
Simply Wall St. via Yahoo Finance· 4 days agoMany Bristol-Myers Squibb Company (NYSE:BMY) insiders ditched their stock over the past year, which...
Big Pharma layoffs continue, as Bristol-Myers Squibb cuts 2,200 jobs, $1.5B in costs
BenefitsPRO· 2 days agoAt a time when drugmakers Eli Lilly & Co. and Novo Nordisk are scrambling to meet demand for their...
Bristol-Myers Gets FDA Acceptance of Review for Subcutaneous Opdivo Formulation
Market Watch· 6 days agoBristol Myers Squibb on Monday said the Food and Drug Administration has accepted its application seeking approval of an subcutaneous formulation of its blockbuster cancer drug Opdivo. The Princeton ...
2 Beaten-Down Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 2 days agoIt's easy to find stocks that are lagging broader equities, even in a bull market like the one we're currently in. It's harder to find beaten-down stocks...
Insider Buying: BOERNER CHRISTOPHER S., Bristol-Myers Squibb Co. [BMY] Chief Executive Officer...
Knox Daily· 4 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bristol-Myers Squibb Co. shares valued at $99,560 were purchased ...
